MedTrace Logo

Combined Use of Naldebain® ER Injection and Precedex® After VATS

NCT06176222 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-12-19

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the effects of combined use of Naldebain® ER Injection and Precedex® in patients received video-assisted thoracoscopic surgery. The main questions it aims to answer are:

* the pain intensity after surgery
* the level of dizziness after surgery Participants will receice ultrasound-guided thoracic paravertebral nerve block, intramuscular Naldebain® ER injection and intravenous Precedex® infusion.

If there is a comparison group: Researchers will compare experimental group with placebo group to see if pain and dizziness after surgery can reduced.

Conditions

  • Acute Post Operative Pain
  • Chronic Post Operative Pain
  • Postoperative Complications

Interventions

DRUG

PRECEDEX INJ★ 2ML

patient received PRECEDEX INJ★ 2ML 0.1\~0.4 mcg/kg/hr intravenous infusion 12 hours after the surgery immediately

DRUG

Normal saline

patient received Normal Saline 0.1 ml/kg/hr intravenous infusion 12 hours after the surgery immediately

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Principal Investigators

  • Hung-Te Hsu, MD, PhD · Department of anesthesiology, Kaohsiung Medical University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-28
Primary Completion
2025-12-31
Completion
2026-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06176222 on ClinicalTrials.gov